Outcome | No / Total No (%) | 95%CI |
---|---|---|
Malaria parasitaemia | 11/352 (3.12) | [1.56-5.59] |
Intestinal parasite carriage | 97/352 (27.56) | [22.35-33.62] |
Isolated intestinal parasites | Â | Â |
Giardia intestinalis | 43/352 (12.22) | [8.84-16.45] |
Entameaba coli | 61/352 (17.33) | [13.25-22.26] |
Strongyloides stercoralis | 02/352 (0.57) | [0.06-2.05] |
Genetic disorders | Â | Â |
G6PD A | 07/352 (1.99) | [0.79-4.09] |
G6PD A- | 03/352 (0.85) | [0.17-2.49] |
Alpha-thalassemia (Hetero+Homozygote) | 78/352 (22.16) | [17.51-27.65] |
Heterozygote (αα/-α) | 62/352 (17.61) | [13.50-22.58] |
Homozygote (−α/-α) | 16/352 (4.55) | [2.60-7.38] |
Sickle cells disorders (HBSS + HBAS +HbAC) | 45 (12.78) | [9.32-17.10] |
Sickle cell disease (HBSS) | 10/352 (2.84) | [1.36-5.22] |
Sickle cell trait (HBAS, C) | 33/352 (9.38) | [6.45-13.17] |
Malnutrition | Â | Â |
Stunting | 136/352 (38.64) | [32.42-45.70] |
Underweight | 91/352 (25.85) | [20.81-31.74] |
Wasting | 33/352 (9.38) | [6.45-13.17] |